ACM Research (ACMR) Tops Q3 EPS by 21c; narrows FY23 guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ACMR Hot Sheet
Price: $44.43 -1.99%
EPS Growth %: +36.1%
Financial Fact:
Cost of sales (including buying and distribution costs): 59.82M
Today's EPS Names:
COHR, ATS, SICP, More
EPS Growth %: +36.1%
Financial Fact:
Cost of sales (including buying and distribution costs): 59.82M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
ACM Research (NASDAQ: ACMR) reported Q3 EPS of $0.57, $0.21 better than the analyst estimate of $0.36. Revenue for the quarter came in at $168.57 million versus the consensus estimate of $171.68 million.
GUIDANCE:
ACM Research sees FY2023 revenue of $520-540 million, versus the consensus of $555.4 million.
For earnings history and earnings-related data on ACM Research (ACMR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q1 EPS by 2c; Offers Guidance
- Arcutis Biotherapeutics, Inc. (ARQT) Misses Q3 EPS by 12c; Offers Guidance
- APA Corporation (APA) Tops Q3 EPS by 38c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
